Login here to update your profile  
My Profile

Ingrid Bahner,  Ph.D.
Associate Professor, Department of Molecular Medicine, College of Medicine


Assoc Professor

profile Image
Email: ibahner@health.usf.edu
Phone: (813) 974-3454
Office: MDC, 4005
Mailing address USF-Morsani College of Medicine, Dept of Molecular Medicine 12901 Bruce B. Downs Blvd., MDC 7
Tampa, FL 33612
View My C. V.
  • Ph.D., Microbiology, University of Southern California ,USA - 1996.
  • PHD, Microbiology, University Of Southern California , United States - 1996.
    Interdisciplinary & Emerging Signature Programs
    Academic Philosophy

    To advance the academic mission of generating knowledge and of delivering excellent education and fostering the intellectual growth of students in a collegial and diverse environment.

    Research Summary

    Specific research interests include: • The role of basic science in the teaching of medical sciences • The role scholarship in improving patient outcome • The role of mentorship in pipeline programs


    Selected Publications
  • Giannoni, F.Hardee, CL.Wherley, J.Gschweng, E.Senadheera, S.Kaufman, ML.Chan, R.Bahner, I.Gersuk, V.Wang, X.Gjertson, D.Baltimore, D.Witte, ON.Economou, JS.Ribas, A.Kohn, DB. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells. Molecular therapy : the journal of the American Society of Gene Therapy. 21(5): 1044-54, 2013.
  • Bahner,I.; Somboonwit,C.; Pross,S.; Collins,R.J. and Saporta,S. Teaching Science Through Biomedical Research In An Elective Curriculum Medical Science Educator. 22(3): 143-146, 2012.
  • Huang, SH.Wu, CH.Jiang, S.Bahner, I.Lossinsky, AS.Jong, AY. HIV-1 gp41 ectodomain enhances Cryptococcus neoformans binding to human brain microvascular endothelial cells via gp41 core-induced membrane activities. The Biochemical journal. 438(3): 457-66, 2011.
  • Taylor, JA.Vojtech, L.Bahner, I.Kohn, DB.Laer, DV.Russell, DW.Richard, RE. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. Molecular therapy : the journal of the American Society of Gene Therapy. 16(1): 46-51, 2008.
  • Bahner, I.Sumiyoshi, T.Kagoda, M.Swartout, R.Peterson, D.Pepper, K.Dorey, F.Reiser, J.Kohn, DB. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Molecular therapy : the journal of the American Society of Gene Therapy. 15(1): 76-85, 2007.
  • Nightingale, SJ.Hollis, RP.Pepper, KA.Petersen, D.Yu, XJ.Yang, C.Bahner, I.Kohn, DB. Transient gene expression by nonintegrating lentiviral vectors. Molecular therapy : the journal of the American Society of Gene Therapy. 13(6): 1121-32, 2006.
  • Unwalla, HJ.Li, HT.Bahner, I.Li, MJ.Kohn, D.Rossi, JJ. Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein. Journal of virology. 80(4): 1863-73, 2006.
  • Michienzi, A.Cagnon, L.Bahner, I.Rossi, JJ. Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proceedings of the National Academy of Sciences of the United States of America. 97(16): 8955-60, 2000.
  • Kohn, DB.Bauer, G.Rice, CR.Rothschild, JC.Carbonaro, DA.Valdez, P.Hao, Q.Zhou, C.Bahner, I.Kearns, K.Brody, K.Fox, S.Haden, E.Wilson, K.Salata, C.Dolan, C.Wetter, C.Aguilar-Cordova, E.Church, J. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood. 94(1): 368-71, 1999.
  • Verma, S.Woffendin, C.Bahner, I.Ranga, U.Xu, L.Yang, ZY.King, SR.Kohn, DB.Nabel, GJ. Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer. Gene therapy. 5(5): 692-9, 1998.
  • Bauer, G.Valdez, P.Kearns, K.Bahner, I.Wen, SF.Zaia, JA.Kohn, DB. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood. 89(7): 2259-67, 1997.
  • Bahner, I.Kearns, K.Coutinho, S.Leonard, EH.Kohn, DB. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood. 90(5): 1787-98, 1997.
  • Kearns, K.Bahner, I.Bauer, G.Wei, SF.Valdez, P.Wheeler, S.Woods, L.Miller, R.Casciato, D.Galpin, J.Church, J.Kohn, DB. Suitability of bone marrow from HIV-1-infected donors for retrovirus-mediated gene transfer. Human gene therapy. 8(3): 301-11, 1997.
  • Zhou, C.Bahner, I.Rossi, JJ.Kohn, DB. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition. Antisense & nucleic acid drug development. 6(1): 17-24, 1996.
  • Bahner, I.Kearns, K.Hao, QL.Smogorzewska, EM.Kohn, DB. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. Journal of virology. 70(7): 4352-60, 1996.
  • Zhou, C.Bahner, IC.Larson, GP.Zaia, JA.Rossi, JJ.Kohn, EB. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene. 149(1): 33-9, 1994.
  • Bahner, I.Zhou, C.Yu, XJ.Hao, QL.Guatelli, JC.Kohn, DB. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. Journal of virology. 67(6): 3199-207, 1993.
  • Bedgood, RM.Bahner, I.Kohn, DB.Stallcup, MR. Two different genes coding for processable and nonprocessable forms of a viral envelope protein can account for the apparent hormonal stimulation of protein processing in W7MG1 lymphoma cells. Molecular endocrinology (Baltimore, Md.). 6(3): 459-67, 1992.
  • Nolta, JA.Yu, XJ.Bahner, I.Kohn, DB. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. The Journal of clinical investigation. 90(2): 342-8, 1992.
  • Kohn, DB.Nolta, JA.Weinthal, J.Bahner, I.Yu, XJ.Lilley, J.Crooks, GM. Toward gene therapy for Gaucher disease. Human gene therapy. 2(2): 101-5, 1991.
  • Bahner, I.Lamb, J.Mayo, MA.Hay, RT. Expression of the genome of potato leafroll virus: readthrough of the coat protein termination codon in vivo. The Journal of general virology. 71 ( Pt 10)(): 2251-6, 1990.

  • Positions Held
  • Clinical Associate Professor (Department of Molecular Microbiology and Immunology, USC-Keck School of Medicine 2007 - 2008)
  • Research Associate Professor (Department of Pediatrics, Division of Research Immunology and Bone Marrow Transplantation, Childrens Hospital Los Angeles 2001 - 2008)
  • Clinical Assistant Professor (Department of Molecular Microbiology and Immunology, USC-Keck School of Medicine 2001 - 2007)

  • Memberships
  • International Association of Medical Science Educators (Member, 2013 - Present)
  • American Society for Microbiology (Member, 2002 - Present)
  • American Society for Gene Therapy (Member, 2001 - 2008)

  • Awards/Honors
  • Outstanding teacher award (University of Southern California - 2008)

  • Lectures
  • "Do Scholarly Concentration Programs Contribute To Lasting Scholarship?" 2014 AAMCSGEA Meeting. FL, United States - 2014.
  • "Workshop on Scholarly Concentrations Program-How to Successfully Foster Medical Student Scholarship " 18th annual IAMSE conference. TN, United States - 2014.
  • "Teaching Scientific Research Skills in an Elective Curriculum: Obstacles, Opportunities and Outcome" IAMSE Webinar. FL, United States - 2013.
  • "Contributions of the scholarly concentration program in biomedical research to the scientific compet" 17th annual IAMSE conferene. United Kingdom - 2013.
  • "Workshop on Designing “return to basic science” curricula for senior health science students" 17th annual IAMSE conferene. United Kingdom - 2013.
  • "CD34+ cell medicated manipulations of the immune response. " Division of Allergy and Immunology, Children's Hospital. FL, United States - 2007.
  • "Development of an HIV-1 integrase inhibitor assay" 21st UARP HIV/AIDS Investigators' Meeting. CA, United States - 2006.

  • Profile last modified on 07/22/2014